What is Pulpdent?
Pulpdent Corporation operates as a family-owned enterprise specializing in the development of bioactive and biomimetic dental materials. For over seven decades, the company has maintained a rigorous focus on clinical education and patient-centered care, establishing itself as a cornerstone of modern restorative dentistry. Its flagship product, ACTIVA BioACTIVE, represents a significant technological advancement, offering a restorative solution that mimics the properties of natural teeth. By stimulating the formation of apatite and creating a chemical bond with tooth structure, Pulpdent provides clinicians with tools that actively protect against decay, thereby setting a high standard for material performance in the dental industry.
How much funding has Pulpdent raised?
Pulpdent has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Pulpdent
PPP
Public-Private Partnership
What's next for Pulpdent?
The infusion of capital marks a pivotal transition for Pulpdent as it moves to solidify its leadership in the bioactive materials space. Future strategic initiatives are expected to focus on the acceleration of research and development pipelines, specifically targeting the next generation of biomimetic restorative solutions. By leveraging this major strategic investment, the company aims to enhance its manufacturing infrastructure and broaden its international distribution networks. As the dental industry shifts toward more preventative and biologically integrated treatments, Pulpdent is strategically aligned to capitalize on these trends, ensuring sustained growth and continued innovation in clinical restorative care.
See full Pulpdent company page
